Ad
related to: pfizer pharmaceuticalsSmall Molecule APIs, Large Molecule Biologics, API's & Intermediates, SIs, and OSDs. There’s no limit to what we can achieve together.
- Reliable Execution &...
High Quality Sterile Injectable
manufacturing. Order now!
- Drug Products
A full range of manufacturing
capabilities and packaging...
- Reliable Execution &...
Search results
Biotechnology is our foundation. Benefiting patients is our goal. Innovation, pharmaceutical development, and the most dedicated team of clinical researchers is how we do it. Explore Our Science
- Careers
Depending on the customs and laws of a specific country,...
- Products
In this section find an overview of our Pfizer Products and...
- Contact Us
Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192...
- Newsroom
Pfizer surveyed adults in 10 countries across the Global...
- Executives
Terramycin also marks the beginning of the Pfizer...
- History
Terramycin® (oxytetracycline), a broad-spectrum antibiotic...
- Announcements
02.23.2024 Diversity & Inclusion Employees Responsibility...
- Updates and Statements
10.05.2023 Medicines FDA Grants Interchangeable Designation...
- About
Recognizing that the key to Pfizer's future growth lies in...
- Careers
Pfizer Inc. (/ ˈ f aɪ z ər / FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
- c. 83,000 (2022)
- 1849; 174 years ago in New York City
- US$100.3 billion (2022)
- The Spiral, New York City, U.S.
May 6, 2024 · IR@Pfizer.com. +1 (212) 733-4848. Source: Pfizer Inc. Share. Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla.
Sep 11, 2023 · Pfizer and BioNTech have submitted data for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine to other regulatory authorities around the world. The COVID-19 vaccines (COMIRNATY®) by Pfizer and BioNTech are based on BioNTech’s proprietary mRNA technology and were developed by both companies.
Aug 23, 2021 · FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease ...